 Belgium
to buy 10,000 courses each of Pfizer and Merck COVID-19 pills
Send a link to a friend
[January 03, 2022]
BRUSSELS (Reuters) - Belgium will buy
10,000 courses each of the COVID-19 antiviral oral treatments developed
by Pfizer and Merck & CO, a spokesman for the health ministry said in an
emailed statement.
|
|
 Belgium's health minister said in early December that the government
was in talks with Merck for the purchase of molnupiravir, and
Belgian health authorities had advised that both molnupiravir and
Paxlovid, the drug developed by Pfizer, should be purchased.
"Both talks are finalised and we will buy 10,000 of both," Arne
Brinckman, a spokesman for the Belgian health ministry told Reuters
on Monday.
[to top of second column] |
 (Reporting by Francesco Guarascio @fraguarascio; Editing by David
Goodman)
[© 2022 Thomson Reuters. All rights
reserved.] Copyright 2022 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
